Clinical Trial Update: A First-in-human Clinical Trial to Evaluate an Alpha-radiation Imaging Agent [EARLY_Phase 1]

View source ↗

Summary

This Clinical Trial Update reports a first-in-human Phase 1 trial of an alpha-radiation imaging agent for neuroendocrine tumors (Grade 1 and Grade 2); the study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroendocrine Tumor

Snippet

Sponsor: Yusuf Menda | Conditions: Neuroendocrine Tumor Grade 2, Neuroendocrine Tumor Grade 1 | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING